BCL2 and acute lymphoblastic leukemia: Interestingly, in CD34+ LSC‐enriched fractions from three T‐ALL patient samples and three normal CD34+ cord blood samples validated a significant upregulation of the long pro‐survival isoforms BCL2 and MCL1, but no significant difference in the isoform expression of BCLX (Figure 3D).